Pancreatic Cancer Research

ResearcherUniversity Hospital MünsterNo recent work listed

Norbert J. Senninger

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0945-9697; OpenAlex author ID A5064531404. Sources: OpenAlex.

Their work

Papers
11 (first author 1, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
11
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: 2 papers · 2016: 1 paper · 2017: 2 papers · 2018: 3 papers · 2019: 1 paper · 2020: none · 2021: 1 paper

Papers 11

  1. Postoperative pancreatic fistula affects recurrence-free survival of pancreatic cancer patients. Last author DOI 10.1371/journal.pone.0252727↗
  2. Clinical impact of circulating LAPTM4B-35 in pancreatic ductal adenocarcinoma. First author DOI 10.1007/s00432-019-02863-w↗
  3. Circulating microRNA-99 family as liquid biopsy marker in pancreatic adenocarcinoma. Co-author DOI 10.1007/s00432-018-2749-7↗
  4. The ambiguous role of microRNA-205 and its clinical potential in pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00432-018-2755-9↗
  5. Clinical Impact of Epithelial-to-Mesenchymal Transition Regulating MicroRNAs in Pancreatic Ductal Adenocarcinoma. Last author DOI 10.3390/cancers10090328↗
  6. Comment on: MicroRNA Expression as a Predictive Marker for Gemcitabine Response After Surgical Resection of Pancreatic Cancer. Last author DOI 10.1245/s10434-017-6207-6↗
  7. Challenges in pancreatic adenocarcinoma surgery - National survey and current practice guidelines. Co-author DOI 10.1371/journal.pone.0173374↗
  8. SERPINB5 Promoter Hypomethylation Differentiates Pancreatic Ductal Adenocarcinoma From Pancreatitis. Co-author DOI 10.1097/mpa.0000000000000526↗
  9. MicroRNA-100 and microRNA-21 as markers of survival and chemotherapy response in pancreatic ductal adenocarcinoma UICC stage II. Co-author DOI 10.1186/s13148-015-0166-1↗
  10. MicroRNA Profiling Implies New Markers of Gemcitabine Chemoresistance in Mutant p53 Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1371/journal.pone.0143755↗
  11. Role of tumor microenvironment on gene expression in pancreatic cancer tumor models. Co-author DOI 10.1016/j.jss.2010.03.034↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Sameer Abdallah Dhayat · 10 shared papers, 2015–2021 · strength 0.92
  2. Wolf Arif Mardin · 5 shared papers, 2011–2017 · strength 0.32
  3. Anda Ströse · 3 shared papers, 2015–2018 · strength 0.23
  4. Jörg Haier · 4 shared papers, 2011–2016 · strength 0.21
  5. Konrad Steinestel · 2 shared papers, 2018 · strength 0.18
  6. Max M. Träger · 2 shared papers, 2018 · strength 0.18
  7. Soeren Torge Mees · 3 shared papers, 2011–2016 · strength 0.15
  8. Isabelle Flammang · 1 shared paper, 2019 · strength 0.12
  9. Qifa Ye · 1 shared paper, 2019 · strength 0.12
  10. Zixuan Yang · 1 shared paper, 2019 · strength 0.12
  11. Thorsten Vowinkel · 1 shared paper, 2017 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.